BIOLASE Inc. - BIOL Company Long-Term Liabilities

Graphic logo of BIOLASE Inc. (BIOL)

BIOLASE, Inc. (BIOL) faces physician inertia and negative operational margins, yet generates revenue through recurring sales of replacement nozzles for its equipment. This chart illustrating the price evolution of the quotes demonstrates the asset's dynamics, where the indicator stands at 0.00. Meanwhile, limited cash flow and significant expenses force the company to constantly seek external financing to maintain liquidity.

BIOL BIOLASE, Inc.: Company Long-Term Debts in the range 07/04/2022 - 08/04/2024

Analytical breakdowns for Biolase, Inc. (BIOL)

- price and consensus price forecast:
Market Price biolase.com|BIOL - Analyst Consensus Forecast
- market capitalization data:
Market Valuation BIOLASE|BIOL - Enterprise Value
- book capitalization data:
Net Assets per Share BIOLASE|BIOL - Book Capitalization|Market Capitalization to Book Value Ratio biolase.com|BIOL - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity BIOLASE, Inc.|BIOL - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Biolase Inc.|BIOL - Company Total Debt|Debts to Book Capitalization Ratio BIOLASE|BIOL - Company Long-Term Debts|Short-Term Debt BIOLASE
Basic company analysis:BIOL (biolase.com)
Original product of BIOLASE, Inc.

Under crisis management conditions, BIOLASE, Inc. finds cost optimization critical for maintaining its listing. This metric captures the aggregate of obligations with a maturity of over one year, determining the issuer's long-term financial stability. Analyzing the firm's long-term debt levels allows for tracking credit load dynamics outside of quarterly reports. A reduction in debt confirms business stabilization, while an increase signals liquidity risks. This is a key factor in determining the company's fair market value.

Direct competitors

Long-Term Debt bostonscientific.com BSX|EW: Company Long-Term Debts|RMD - Company Long-Term Liabilities|OmniPod - Company Long-Term Debts|Zimmer Biomet Holdings, Inc. (ZBH) - Long-Term Debt Volume|COO (The Cooper Companies) - Company Long-Term Debts|Company Long-Term Debts ALGN|Company Long-Term Debt Globus Medical (GMED)|Company Long-Term Debt TransMedics Group (TMDX)|Company Long-Term Debts ATEC|AORT - Long-Term Debt Volume|Company Long-Term Liabilities Enovis Corporation|IART - Long-Term Liabilities|Company Long-Term Debts ESTA|Beta Bionics, Inc. (BBNX) - Long-Term Debt|Company Long-Term Debts Iradimed (IRMD)|Company Long-Term Indebtedness Embecta Health (EMBC)|Tandem Diabetes Care (TNDM) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings AXGN (axogeninc.com)|SI-BONE - Company Long-Term Debt|Company Long-Term Liabilities Orthofix Medical OFIX|BVS (Bioventus Corp) - Company Long-Term Debts|KIDS - Long-Term Debt|Company Long-Term Debts Treace Medical Concepts|blade.com (SRTA) - Company Long-Term Indebtedness|CARL: Company Long-Term Debts|Long-Term Debt Volume RxSight Inc|Company Long-Term Debts CLPT (ClearPoint Neuro, Inc.)|Company Long-Term Liabilities Stereotaxis Corporation (STXS)|Company Long-Term Debts STIM (Neuronetics, Inc.)|sightsciences.com - Company Long-Term Debts|OBIO - Company Long-Term Debt|Anika Therapeutics (ANIK) - Company Long-Term Debt|Company Long-Term Liabilities InspireMD Corp NSPR|Jin Medical (ZJYL) - Company Long-Term Loans and Borrowings|Company Long-Term Debts VANI (Vivani Medical Inc)|Long-Term Debt XTNT|NMTC: Company Long-Term Debt|Long-Term Indebtedness modular-medical.com MODD|Company Long-Term Liabilities MYO (Myomo, Inc)|Company Long-Term Debts Envoy Medical Inc COCH|Company Long-Term Debts VVOS (Vivos Therapeutics)|NVNO: Long-Term Debt Volume|Company Long-Term Debt sintx.com (SINT)|TNON (Tenon Medical Inc.) - Long-Term Liabilities|Company Long-Term Debt LFWD|Company Long-Term Liabilities Autonomix|INVO Fertility Inc - Company Long-Term Debts|Long-Term Debt BBLG (bonebiologics.com)|AXNX - Company Long-Term Debt|DYNT - Company Long-Term Indebtedness|Company Long-Term Liabilities Paragon 28 Corp FNA|INVO - Amount of Long-Term Liabilities